Related Experiment Videos
[Evaluation of esophageal endoprosthesis]
N Landoni1, A Palazzolo, N Chopita
1Servicio de Gastroenterología del H.I.G.A. San Martín, La Plata, Argentina.
Acta Gastroenterologica Latinoamericana
|January 1, 1990
Summary
Esophageal endoprosthesis therapy is effective for non-operable esophageal conditions, primarily esophageal carcinoma. While perforation is a risk, endoscopic reimplantation offers a solution, though bronchoaspiration remains a significant mortality cause.
Area of Science:
- Gastroenterology
- Oncology
- Surgical Innovation
Context:
- Assesses esophageal endoprosthesis therapy in 60 patients with non-operable esophageal pathology.
- Focuses on conditions involving neighboring organs with esophageal involvement.
- Highlights implantation techniques and patient outcomes.
Purpose:
- To evaluate the efficacy and safety of esophageal endoprosthesis therapy.
- To identify primary indications and associated morbimortality.
- To determine optimal management strategies for complications.
Summary:
- Esophageal endoprosthesis therapy was applied in 60 patients with non-operable esophageal conditions, predominantly epidermoid esophageal carcinoma (48 cases) and gastric adenocarcinoma with esophageal involvement (9 cases).
- Early complications included perforation in 4 patients. The overall mortality rate was 16.9% (10 cases), with bronchoaspiration being the main cause.
- Endoscopic reimplantation of the prosthesis was the preferred treatment for perforated cases.
Impact:
- Provides insights into managing complex esophageal pathologies where surgery is not an option.
- Informs clinical decision-making regarding the use of esophageal endoprostheses.
- Highlights the importance of managing complications like perforation and bronchoaspiration.